SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-22-000239
Filing Date
2022-03-24
Accepted
2022-03-24 09:00:25
Documents
13
Period of Report
2022-03-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 26358
  Complete submission text file 0001553350-22-000239.txt   241006

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE htbx-20220318.xsd EX-101.SCH 3548
3 XBRL DEFINITION FILE htbx-20220318_def.xml EX-101.DEF 26839
4 XBRL LABEL FILE htbx-20220318_lab.xml EX-101.LAB 36783
5 XBRL PRESENTATION FILE htbx-20220318_pre.xml EX-101.PRE 25461
7 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 5069
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 22764844
SIC: 2834 Pharmaceutical Preparations